copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Breakthrough science | Portfolio business | Apollo Therapeutics We translate breakthroughs in biology and basic medical research into innovative new medicines With over 20 active therapeutic programs, six of which are in development, we are building a large, diversified portfolio of novel therapeutics with uncorrelated risk We are located in Cambridge and Oxford, UK, and Boston and Chicago, USA
Home | Apollo Therapeutics At Apollo Therapeutics, we pioneer transformative biotech and healthcare solutions for both humans and companion animals From preventive care to advanced therapeutic technologies, our mission is to enhance life at every stage—across species
Apollo Biotech – Assaya Apollo BioTech is now Assaya provides affordable and equitable human error reducing diagnostics at scale, with real-time reporting Our mission is to provide the world with reliable, augmented, practical, and inexpensive diagnostics (RAPID) that can be deployed anywhere, anytime, to identify biomarkers and dangerous pathogens in near real-time
Apollo Therapeutics - LinkedIn Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries
Apollo takes off with $226M series C - Fierce Biotech Apollo Therapeutics is launching its series C flight with $226 5 million, money that will bolster its hub-and-spoke approach to drug development encompassing 20-plus pipeline programs that
About Us - Apollo Therapeutics We translate breakthroughs in biology and basic medical research into innovative new medicines With over 20 active therapeutic programs, six of which are in development, we are building a large, diversified portfolio of novel therapeutics with uncorrelated risk
Apollo Therapeutics Apollo Therapeutics is a portfolio biotech company that develops a pipeline of clinical-stage drug discovery programs to generate breakthrough discoveries and create value for investors, stakeholders and patients in high-value markets
AZ, J J and GSK team up with universities to create Apollo . . . To be named the Apollo Therapeutics Fund, the joint venture will support the translation of ground-breaking academic science from within the universities into innovative new medicines for a broad